Elevation Oncology, Inc. (ELEV) DCF Valuation

Elevation Oncology, Inc. (ELEV) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Elevation Oncology, Inc. (ELEV) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your Elevation Oncology, Inc. (ELEV) valuation analysis with our sophisticated DCF Calculator! This Excel template comes preloaded with real (ELEV) data, enabling you to adjust forecasts and assumptions for an accurate calculation of Elevation Oncology's intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -5.9 -17.3 -32.0 -94.5 -41.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 3.6 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -9.5 -17.3 -32.0 -94.5 -41.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 1.7 79.4 146.3 90.3 83.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .5 5.7 5.6 6.4 .5 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.1 .0 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -0.06568288 -0.06568288 -0.06568288 -0.06568288 -0.06568288 -0.06568288 -0.06568288 -0.06568288 -0.06568288 -0.06568288
EBITAT -9.5 -17.3 -32.0 -94.6 -41.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.4 -12.1 -32.1 -93.9 -47.3 -.5 .0 .0 .0 .0
WACC, % 12.43 12.43 12.43 12.43 12.43 12.43 12.43 12.43 12.43 12.43
PV UFCF
SUM PV UFCF -.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -19
Equity Value 19
Diluted Shares Outstanding, MM 34
Equity Value Per Share 0.55

What You Will Receive

  • Pre-Filled Financial Model: Elevation Oncology’s actual data enables accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
  • Real-Time Calculations: Instant updates ensure you see outcomes as you implement changes.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
  • Customizable and Reusable: Designed for adaptability, allowing repeated use for in-depth forecasts.

Key Features

  • Comprehensive Financial Data: Gain access to precise pre-loaded historical data and future forecasts for Elevation Oncology, Inc. (ELEV).
  • Adjustable Forecast Parameters: Modify highlighted cells for key metrics like WACC, growth rates, and profit margins.
  • Real-Time Calculations: Instant updates to DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to easily interpret your valuation outcomes.
  • Suitable for All Skill Levels: A straightforward, intuitive design tailored for investors, CFOs, and consultants alike.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based ELEV DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
  3. Instant Calculations: The model automatically recalculates Elevation Oncology’s intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the findings to inform your investment or financial analysis.

Why Choose This Calculator?

  • Accuracy: Leverages real Elevation Oncology financials for precise data.
  • Flexibility: Tailored for users to easily test and adjust inputs as needed.
  • Time-Saving: Avoid the complexities of creating a DCF model from the ground up.
  • Professional-Grade: Crafted with the precision and usability expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users without advanced financial modeling skills.

Who Should Use This Product?

  • Investors: Accurately assess Elevation Oncology's fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis.
  • Consultants: Easily customize the template for valuation reports tailored to clients.
  • Entrepreneurs: Understand financial modeling techniques applied by leading biotech firms.
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Elevation Oncology, Inc. (ELEV).
  • Real-World Data: Elevation Oncology’s historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios specific to Elevation Oncology, Inc. (ELEV).
  • Financial Statements: Full annual and quarterly breakdowns for deeper insights into Elevation Oncology's performance.
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage relevant to Elevation Oncology, Inc. (ELEV).
  • Dashboard with Visual Outputs: Charts and tables for clear, actionable results regarding Elevation Oncology, Inc. (ELEV).

No products were found matching.